(Q39092457)

9 September 2017

Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals (English)

1 reference

Human T-lymphotropic virus 1

9 September 2017

0 references

author name string

H Ida

1

1 reference

9 September 2017

A Kurata

2

1 reference

9 September 2017

K Eguchi

3

1 reference

9 September 2017

A Kawakami

4

1 reference

9 September 2017

K Migita

5

1 reference

9 September 2017

T Fukuda

6

1 reference

9 September 2017

T Nakamura

7

1 reference

9 September 2017

Y Kusumoto

8

1 reference

9 September 2017

J A Berzofsky

9

1 reference

9 September 2017

S Nagataki

10

1 reference

9 September 2017

1 May 1991

1 reference

Journal of Clinical Immunology

9 September 2017

1 reference

9 September 2017

11

1 reference

9 September 2017

3

1 reference

9 September 2017

143-151

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00918682

9 September 2017

0 references

cites work

Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.

1 reference

12 December 2020

A gag-env hybrid protein of human T-cell leukemia virus type I and its application to serum diagnosis

1 reference

12 December 2020

Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease

1 reference

12 December 2020

Immunodominant B-cell epitopes of the HIV-1 envelope recognized by infected and immunized hosts

1 reference

12 December 2020

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

1 reference

12 December 2020

HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma.

1 reference

12 December 2020

Automated Synthesis of Peptides

1 reference

12 December 2020

Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells

1 reference

12 December 2020

HTLV-I associated myelopathy, a new clinical entity.

1 reference

12 December 2020

HTLV-I and HTLV-III antibodies and tropical spastic paraparesis.

1 reference

12 December 2020

Protein antigenic structures recognized by T cells: potential applications to vaccine design

1 reference

12 December 2020

Monoclonal antibodies against human T cell leukemia-lymphoma virus (HTLV) p24 internal core protein. Use as diagnostic probes and cellular localization of HTLV

1 reference

12 December 2020

Prediction of immunodominant helper T cell antigenic sites from the primary sequence

1 reference

12 December 2020

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

1 reference

12 December 2020

T-cell antigenic sites tend to be amphipathic structures

1 reference

12 December 2020

Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein.

1 reference

12 December 2020

Chronic inflammatory arthropathy associated with HTLV-I.

1 reference

12 December 2020

Human T-cell leukemia virus type I: induction of syncytia and inhibition by patients' sera

1 reference

12 December 2020

The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group

1 reference

12 December 2020

Infection of human endothelial cells by human T-cell leukemia virus type I

1 reference

12 December 2020

Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis

1 reference

12 December 2020

HTLV-I polymyositis in a patient also infected with the human immunodeficiency virus

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00918682

1 reference

9 September 2017

1 reference